Stay updated with breaking news from Roberth Dworkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Confo Therapeutics today announced the establishment of its Medical Advisory Board (MAB). The MAB will provide external review and strategic advice for the company's clinical development program including
Understanding the Shingles Vaccine Over 500,000 Americans get the painful illness shinglesshingles every year. But that could be changing. In May 2006, the FDA approved the first shingles vaccine -- called Zostavax -- for people 60 and older. "It's a very important vaccine," says Robert H. Dworkin, PhD, a professor in the department of anesthesiology at the University of Rochester Medical Center in Rochester, N.Y. "It cuts the risk of developing shingles in half." While shingles could be treated with antiviral drugs to lessen its impact, up until now, doctors had no way to prevent it. Shin...